Clinical Social Workers in Wilmington, IL Accepting Medicare

4 Clinical Social Workers found. Showing 1 - 4

Mary Therese Boyle, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 523 Barnes Dr, Wilmington, IL 60481 Phone: 773-330-7102

Mrs. Kathleen Mary Burgess, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 19581 W Ballou Rd, Wilmington, IL 60481 Phone: 815-476-6589

Kimberly Irene Young Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 718 E Baltimore St, Wilmington, IL 60481 Phone: 815-474-2468

Mr. Chester Joseph Dziuban, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 1801 Roberts St, Wilmington, IL 60481 Phone: 815-529-6874

News Archive

Boring jobs can make your heart bad

British researchers say that dull, steady, boring and unexciting jobs are no good for the heart.

Study highlights transitional care importance in health reform

A new study, conducted by Ellen Kurtzman, R.N., M.P.H., FAAN, assistant research professor in the GW School of Nursing, and colleagues, published in the April 2011 issue of Health Affairs, highlights the importance of transitional care in reaching the goals of health reform, and provides evidence-based strategies to guide its implementation.

Study provides new insight into norovirus outbreaks, may help guide efforts to develop vaccines

Outbreaks of norovirus in health care settings and outbreaks caused by a particular genotype of the virus are more likely to make people seriously ill, according to a new study in The Journal of Infectious Diseases.

Bionovo initiates Menerba Phase 3 trial in menopausal hot flashes

Bionovo, Inc., a pharmaceutical company focused on the discovery and development of safe and effective treatments for women's health and cancer, today announced that the first patient has now been randomized and will begin dosing in the Phase 3 pivotal clinical trial evaluating the safety and efficacy of two doses of Menerba (MF101) among a cohort of postmenopausal women for the treatment of menopausal hot flashes.

Once-daily COPD portfolio data from Novartis presented at European Respiratory Society (ERS) Annual Congress

Novartis announced new analyses of data for once-daily Ultibro® Breezhaler® (investigational QVA149 - indacaterol 85 mcg/glycopyrronium 43 mcg delivered dose, equivalent to 110 mcg/50 mcg metered dose per capsule), which showed significant improvements in lung function, shortness of breath and health-related quality of life for chronic obstructive pulmonary disease (COPD) patients versus all comparators1,2. These data were part of 39 respiratory abstracts presented at the European Respiratory Society (ERS) Annual Congress in Barcelona, Spain.

Read more Medical News

› Verified 3 days ago